Camlin Fine Sciences Stock Screener | Share Price & Fundamental Analysis
CAMLINFINE
Specialty Chemicals
Share Price NSE
₹109.39
▲
5.53 (5.32%)
Share Price BSE
₹109.51
▲
5.42 (5.21%)
Track Camlin Fine Sciences share price live with TickJournal's free stock screener.
Analyze Camlin Fine Sciences share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Camlin Fine Sciences Market Cap
₹1,977.78 Cr.
CAMLINFINE P/E Ratio (TTM)
-31.16
Camlin Fine Sciences P/B Ratio
1.97
EPS (TTM)
₹-8.03
Dividend Yield
-
Debt to Equity
0.79
CAMLINFINE 52 Week High
₹231.00
Camlin Fine Sciences 52 Week Low
₹96.93
Operating Margin
7.00%
Profit Margin
-
CAMLINFINE Revenue (TTM)
₹449.00
EBITDA
₹43.00
Net Income
-
Total Assets
₹2,024.00
Total Equity
₹875.00
Camlin Fine Sciences Share Price History - Stock Screener Chart
Screen CAMLINFINE historical share price movements with interactive charts. Analyze price trends and patterns.
Camlin Fine Sciences Company Profile - Fundamental Screener
Screen Camlin Fine Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CAMLINFINE shares.
Sector
Chemicals
Industry
Specialty Chemicals
Sub-Sector
Specialty Chemicals
Segment
E
ISIN
INE052I01032
Camlin Fine Sciences Balance Sheet Screener
Screen CAMLINFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,024 | 1,952 | 2,060 | 1,800 | 1,482 | 1,234 | 1,087 | 1,017 | 673 | 483 |
| Current Assets | 1,183 | 1,001 | 1,088 | 894 | 795 | 675 | 673 | 666 | 419 | 300 |
| Fixed Assets | 704 | 816 | 858 | 601 | 584 | 306 | 272 | 278 | 201 | 140 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 303 | 363 | 443 | 440 | 291 | 226 | 196 | 112 | 57 | 27 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 875 | 857 | 824 | 765 | 713 | 460 | 430 | 433 | 230 | 176 |
| Share Capital | 19 | 17 | 16 | 16 | 13 | 12 | 12 | 12 | 10 | 10 |
| Reserves & Surplus | 880 | 845 | 800 | 729 | 582 | 388 | 335 | 359 | 202 | 167 |
Camlin Fine Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Camlin Fine Sciences income statement and profit fundamentals.
Analyze CAMLINFINE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Camlin Fine Sciences share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 449 | 433 | 464 | 460 | 382 | 383 | 429 | 432 | 429 | 426 | 408 | 388 | 411 | 385 | 486 |
| Expenses | 406 | 411 | 436 | 462 | 446 | 368 | 529 | 384 | 393 | 381 | 381 | 363 | 365 | 337 | 428 |
| EBITDA | 43 | 22 | 29 | -2 | -64 | 14 | -100 | 48 | 36 | 45 | 27 | 25 | 46 | 48 | 58 |
| Operating Profit % | 7.00% | 3.00% | 5.00% | -1.00% | -19.00% | 3.00% | -27.00% | 11.00% | 8.00% | 9.00% | 6.00% | 6.00% | 6.00% | 12.00% | 11.00% |
| Depreciation | 18 | 17 | 19 | 17 | 13 | 15 | 17 | 15 | 18 | 19 | 19 | 21 | 16 | 14 | 14 |
| Interest | 16 | 16 | 19 | 18 | 16 | 23 | 26 | 34 | 10 | 10 | 20 | 14 | 10 | 19 | 19 |
| Profit Before Tax | 8 | -11 | -9 | -37 | -94 | -24 | -142 | 0 | 8 | 16 | -12 | -10 | 20 | 15 | 26 |
| Tax | 8 | 0 | 6 | 0 | -12 | 11 | -26 | 7 | 5 | 4 | 9 | 5 | 7 | 11 | 16 |
| Net Profit | 0 | -11 | -15 | -37 | -82 | -35 | -116 | -8 | 4 | 12 | -21 | -14 | 13 | 4 | 10 |
| EPS | -0.04 | -0.53 | -0.76 | -1.91 | -4.64 | -2.00 | -5.88 | -0.71 | 0.59 | 0.96 | -1.17 | -0.71 | 1.16 | 0.37 | 0.83 |
Camlin Fine Sciences Cash Flow Screener - Liquidity Fundamentals
Screen CAMLINFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 27 | 139 | 51 | 145 | 117 | 86 | -9 | -15 | -9 | 72 |
| Investing Activities | -75 | -67 | -125 | -249 | -133 | -90 | -2 | -149 | -70 | -66 |
| Financing Activities | 72 | -86 | 60 | 136 | 39 | 3 | 26 | 182 | 91 | -7 |
| Net Cash Flow | 24 | -14 | -14 | 32 | 23 | -1 | 15 | 18 | 13 | -1 |
Camlin Fine Sciences Shareholding Pattern Screener
See Camlin Fine Sciences shareholding pattern with promoter, FII, and DII holdings.
Check Camlin Fine Sciences promoter holding and ownership changes for CAMLINFINE on TickJournal.
| Item | 2025-Jan | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Nov | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.10% | 49.10% | 49.10% | 49.08% | 48.03% | 48.03% | 48.03% | 48.02% |
| FII Holding | 0.82% | 1.47% | 2.88% | 2.12% | 2.15% | 2.12% | 1.69% | 1.01% |
| DII Holding | 4.09% | 3.83% | 4.14% | 5.48% | 7.78% | 7.77% | 4.54% | 4.89% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 33.14% | 32.85% | 30.98% | 29.20% | 26.89% | 26.94% | 32.75% | 33.89% |
| Other Holding | 12.85% | 12.75% | 12.89% | 14.13% | 15.15% | 15.13% | 12.99% | 12.19% |
| Shareholder Count | 60,554 | 58,111 | 59,538 | 57,661 | 52,845 | 57,661 | 58,165 | 62,687 |
Camlin Fine Sciences Share Dividend Screener - Share Yield Analysis
Check Camlin Fine Sciences dividend history with payout and yield data.
View Camlin Fine Sciences dividend details including ex-dates and amounts for CAMLINFINE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Camlin Fine Sciences Stock Index Membership
See which indices include Camlin Fine Sciences stock.
Check CAMLINFINE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP
Camlin Fine Sciences Market Events Screener - Corporate Actions
Get Camlin Fine Sciences corporate actions including splits, bonuses, and buybacks.
Check Camlin Fine Sciences stock events that may affect CAMLINFINE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -3.72% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.05% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -8.63% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 26.19% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 9.49% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 5.94% |
| 2025-01-08 | 2025-01-08 | Rights | 5:41 | -2.16% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 16.05% |
| 2024-07-31 | 2024-07-31 | Annual General Meeting | NA | 19.06% |
Camlin Fine Sciences Competitors Screener - Peer Comparison
Screen CAMLINFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 129,623 | 57.43 | 13,388 | 6.91% | 2,096 | 35.70 |
| SRF | 71,619 | 42.58 | 14,826 | 12.13% | 1,251 | 42.38 |
| Gujarat Fluorochemicals | 35,190 | 54.08 | 4,853 | 10.61% | 546 | 48.86 |
| Navin Fluorine International | 30,181 | 56.61 | 2,393 | 12.83% | 289 | 41.36 |
| Himadri Speciality Chemical | 22,611 | 32.10 | 4,664 | 10.33% | 555 | 47.68 |
| Deepak Nitrite | 18,791 | 34.59 | 8,366 | 7.84% | 697 | 42.30 |
| Atul | 18,537 | 31.10 | 5,692 | 18.99% | 499 | 49.36 |
| Aarti Industries | 14,819 | 39.48 | 7,285 | 14.16% | 331 | 45.77 |
| Aether Industries | 14,639 | 68.56 | 880 | 38.11% | 158 | 54.57 |
| Anupam Rasayan | 14,406 | 63.43 | 1,449 | -3.77% | 160 | 51.59 |
Camlin Fine Sciences Company Announcements - News Screener
Screen CAMLINFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-05 | Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015: Intimation Regarding Receipt Of An Order From Office Of The Asst. / Dy. Commissioner Of (CGST & C. Ex.) Division-IV Palghar Commissionerate | - |
| 2026-04-02 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-04-01 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-03-18 | Announcement under Regulation 30 (LODR)-Restructuring | - |
| 2026-03-18 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-03-18 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-03-17 | Press Release Issued By The Company. | - |
| 2026-03-16 | Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Commissioner Of CGST & Central Excise Palghar Commissionerate | - |
| 2026-03-06 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-03-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-28 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-02-20 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-13 | Unaudited Financial Results As On December 31 2025 | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of The Board Meeting Dated February 13 2026 | - |